Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
Credit: GSK KUALA LUMPUR, Sept 10 (Bernama) -- GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of the Herpes Zoster (HZ) vaccine, Shingrix, also known as Recombinant Zoster ...
Shingrix is approved to prevent shingles (herpes zoster ... Also Read: GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech.
Findings showed a noninferior immune response for both vaccines when coadministered compared with separate administration. Topline results were announced from a phase 3 study assessing the immune ...
GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in ...
A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk (from left to right) Dr Alap Gandhi, Country Medical Director of GSK Malaysia and ...
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage ...
A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline ...
A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline Pharmaceutical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback